Literature DB >> 29747285

[Expert consensus on the diagnosis and treatment of cryptococcal meningitis].

Z Y Liu1, G Q Wang, L P Zhu, X J Lyu, Q Q Zhang, Y S Yu, Z H Zhou, Y B Liu, W P Cai, R Y Li, W H Zhang, F J Zhang, H Wu, Y C Xu, H Z Lu, T S Li.   

Abstract

Cryptococcal meningitis is a common and refractory central nervous system infection, with high rates of mortality and disability. The experts of the Society of Infectious Diseases of Chinese Medical Association have reached this consensus after a thorough discussion. Based on the current situation of cryptococcal meningitis in China, the management of cryptococcal meningitis includes 6 aspects: introduction, microorganism identification, clinical manifestations and diagnosis, principles of antifungal therapy, treatment of refractory and recurrent meningitis, treatment of intracranial hypertension. There is not a separate consensus on human immunodeficiency virus (HIV) infection in patients with cryptococcal meningitis. This article focuses on different antifungal regimens and reducing intracranial pressure by reference to Infectious Disease Society of America (IDSA) guidelines. The importance of early diagnosis, combined long-term antifungal therapy, control of intracranial hypertension are emphasized.

Entities:  

Keywords:  Diagnosis; Meningitis, cryptococcal; Treatment

Mesh:

Substances:

Year:  2018        PMID: 29747285     DOI: 10.3760/cma.j.issn.0578-1426.2018.05.003

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  6 in total

1.  Development of a lateral flow recombinase polymerase amplification assay for rapid and visual detection of Cryptococcus neoformans/C. gattii in cerebral spinal fluid.

Authors:  Qinglin Ma; Jilong Yao; Shixin Yuan; Houming Liu; Ning Wei; Jianming Zhang; Wanshui Shan
Journal:  BMC Infect Dis       Date:  2019-02-04       Impact factor: 3.090

2.  The clinical characteristics and outcome of cryptococcal meningitis with AIDS in a tertiary hospital in China: an observational cohort study.

Authors:  Liang Wu; Jiang Xiao; Yangzi Song; Guiju Gao; Hongxin Zhao
Journal:  BMC Infect Dis       Date:  2020-12-01       Impact factor: 3.090

3.  Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study.

Authors:  Junyu Liu; Jia Liu; Xiaohong Su; Lu Yang; Yijie Wang; Anni Wang; Xiaofeng Xu; Min Li; Ying Jiang; Fuhua Peng
Journal:  BMC Neurol       Date:  2022-07-22       Impact factor: 2.903

4.  Chemokine and Cytokine Cascade Caused by Skewing of the Th1-Th2 Balance Is Associated with High Intracranial Pressure in HIV-Associated Cryptococcal Meningitis.

Authors:  Lijun Xu; Yongzheng Guo; Yizhou Zhao; Yufan Xu; Xiuming Peng; Zongxing Yang; Ran Tao; Ying Huang; Yan Xu; Yaokai Chen; Biao Zhu
Journal:  Mediators Inflamm       Date:  2019-12-31       Impact factor: 4.711

5.  Potential Predictors and Survival Analysis of the Relapse of HIV-Associated Cryptococcal Meningitis: A Retrospective Study.

Authors:  Yao Li; Yanqiu Lu; Jingmin Nie; Min Liu; Jing Yuan; Yan Li; Huan Li; Yaokai Chen
Journal:  Front Med (Lausanne)       Date:  2021-05-10

6.  Surgical treatment and operation time in human immunodeficiency virus-negative cryptococcal meningitis.

Authors:  Jie Zhao; Xiang Zhao; Shaobo Yang; Shuying Miao; Ying Liu
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.